The miR-124-3p/Neuropilin-1 Axis Contributes to the Proliferation and Metastasis of Triple-Negative Breast Cancer Cells and Co-Activates the TGF-β Pathway
暂无分享,去创建一个
Yan Shi | Xian Jiang | Xueying Sun | Xuesong Zhang | Ziyi Li | Jiayang Zhang | Qingshan Wang | Xuesong Zhang
[1] Ping Wang,et al. miR-124-3p Regulates FGF2–EGFR Pathway to Overcome Pemetrexed Resistance in Lung Adenocarcinoma Cells by Targeting MGAT5 , 2020, Cancer management and research.
[2] Muhammad Nawaz,et al. miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells via Targeting CRKL , 2020, Frontiers in Molecular Biosciences.
[3] Y. Zhang,et al. Neuropilin1, a novel independent prognostic factor and therapeutic target in triple-negative breast cancer. , 2020, Neoplasma.
[4] J. S. Lee,et al. Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges , 2020, Cancers.
[5] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[6] Stephen T. C. Wong,et al. Differential contributions of pre- and post- EMT tumor cells in breast cancer metastasis. , 2019, Cancer research.
[7] B. Zhai,et al. The miR-141/neuropilin-1 axis is associated with the clinicopathology and contributes to the growth and metastasis of pancreatic cancer , 2019, Cancer Cell International.
[8] L. Saal,et al. Whole-genome-sequencing of triple negative breast cancers in a population-based clinical study , 2019, Nature Medicine.
[9] Junjie Zhao,et al. MicroRNA‐124: An emerging therapeutic target in cancer , 2019, Cancer medicine.
[10] Yang Zhang,et al. Neuropilin 1 modulates TGF-β1-induced epithelial-mesenchymal transition in non-small cell lung cancer , 2019, International journal of oncology.
[11] Hui Wang,et al. RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] M. Al Riyami,et al. Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response , 2019, Front. Oncol..
[13] Y. Bidet,et al. New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer , 2019, Cancers.
[14] F. Sato,et al. Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network , 2018, International journal of cancer.
[15] A. Khan,et al. miRNA‐124‐3p/neuropilin‐1(NRP‐1) axis plays an important role in mediating glioblastoma growth and angiogenesis , 2018, International journal of cancer.
[16] M. Bandehpour,et al. Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues , 2018, Cancer management and research.
[17] D. Mukhopadhyay,et al. Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis. , 2018, Seminars in cancer biology.
[18] Jun Lu,et al. Neuropilin‐1 regulated by miR‐320 contributes to the growth and metastasis of cholangiocarcinoma cells , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[19] M. Al Riyami,et al. Neuropilin-1 Associated Molecules in the Blood Distinguish Poor Prognosis Breast Cancer: A Cross-Sectional Study , 2017, Scientific Reports.
[20] B. Zhai,et al. Dual inhibition of Akt and c‐Met as a second‐line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells , 2017, Molecular oncology.
[21] Xinhan Zhao,et al. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin. , 2016, Cancer letters.
[22] Wassim Raffoul,et al. A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response. , 2016, Cancer cell.
[23] Linhao Li,et al. Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors , 2016, Journal of experimental & clinical cancer research : CR.
[24] S. Estrem,et al. Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway , 2015, Drug design, development and therapy.
[25] Zhen Wang,et al. miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1 , 2015, Bioscience reports.
[26] C. Betsholtz,et al. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis , 2015, Oncogene.
[27] M. Kerin,et al. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring , 2015, Cancer and Metastasis Reviews.
[28] Prahlad T. Ram,et al. Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer , 2015, Oncogene.
[29] Pete E. Pascuzzi,et al. The Antitumorigenic Function of EGFR in Metastatic Breast Cancer is Regulated by Expression of Mig6 , 2015, Neoplasia.
[30] B. Zhai,et al. Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma , 2014, Molecular Cancer Therapeutics.
[31] Samy Lamouille,et al. Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.
[32] Lianfeng Zhang,et al. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells. , 2013, Cellular signalling.
[33] J. Balko,et al. TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer. , 2013, The Journal of clinical investigation.
[34] J. Norman,et al. Neuropilin-1-dependent regulation of EGF-receptor signaling. , 2012, Cancer research.
[35] C. Ling,et al. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. , 2012, Biochemical and biophysical research communications.
[36] Jiri Bartek,et al. Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth , 2012, The Journal of experimental medicine.
[37] Y. Glinka,et al. Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. , 2011, Carcinogenesis.
[38] Pedagógia,et al. Cross Sectional Study , 2019 .
[39] J. Slingerland,et al. p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies , 2010, Clinical Cancer Research.
[40] S. Dent. The role of VEGF in triple-negative breast cancer: where do we go from here? , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[41] R. Crystal,et al. A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition , 2009, Nature Cell Biology.
[42] Y. Glinka,et al. Neuropilin-1 is a receptor for transforming growth factor β-1, activates its latent form, and promotes regulatory T cell activity , 2008, Journal of leukocyte biology.
[43] R. Weinberg,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.
[44] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[45] G. Watkins,et al. The Hepatocyte Growth Factor Regulatory Factors in Human Breast Cancer , 2004, Clinical Cancer Research.
[46] W. Birchmeier,et al. Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.
[47] J. Balko,et al. TGF-b inhibition enhances chemotherapy action against triple-negative breast cancer , 2018 .
[48] Xin-Yun Huang,et al. Mouse models for tumor metastasis. , 2012, Methods in molecular biology.
[49] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.